The pharmaceutical giant Pfizer’s phase 3 clinical trial for a Lyme disease vaccine has hit a snag. Pfizer and vaccine partner Valneva said in a joint statement that they will stop testing the vaccine in about half of the US participants due to “violations of Good Clinical... Read More »